Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy
Erika Pfaunmiller, PhD’s Post
More Relevant Posts
-
Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy
ON-DEMAND WEBINAR: Key challenges and lab solutions in your global cell and gene therapy trials, Mar. 20, 2024 | Labcorp
share.postbeyond.com
To view or add a comment, sign in
-
Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy
ON-DEMAND WEBINAR: Key challenges and lab solutions in your global cell and gene therapy trials, Mar. 20, 2024 | Labcorp
share.postbeyond.com
To view or add a comment, sign in
-
Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy
ON-DEMAND WEBINAR: Key challenges and lab solutions in your global cell and gene therapy trials, Mar. 20, 2024 | Labcorp
share.postbeyond.com
To view or add a comment, sign in
-
Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy
ON-DEMAND WEBINAR: Key challenges and lab solutions in your global cell and gene therapy trials, Mar. 20, 2024 | Labcorp
share.postbeyond.com
To view or add a comment, sign in
-
Business Development Manager | Progressing your drug development journey - Toxicology, Pharmacology, DMPK, IND Enabling Packages, Supporting Western US
Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy
ON-DEMAND WEBINAR: Key challenges and lab solutions in your global cell and gene therapy trials, Mar. 20, 2024 | Labcorp
share.postbeyond.com
To view or add a comment, sign in
-
Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy
ON-DEMAND WEBINAR: Key challenges and lab solutions in your global cell and gene therapy trials, Mar. 20, 2024 | Labcorp
share.postbeyond.com
To view or add a comment, sign in
-
Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy
ON-DEMAND WEBINAR: Key challenges and lab solutions in your global cell and gene therapy trials, Mar. 20, 2024 | Labcorp
share.postbeyond.com
To view or add a comment, sign in
-
Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy
ON-DEMAND WEBINAR: Key challenges and lab solutions in your global cell and gene therapy trials, Mar. 20, 2024 | Labcorp
share.postbeyond.com
To view or add a comment, sign in
-
Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy
ON-DEMAND WEBINAR: Key challenges and lab solutions in your global cell and gene therapy trials, Mar. 20, 2024 | Labcorp
share.postbeyond.com
To view or add a comment, sign in
-
Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy
ON-DEMAND WEBINAR: Key challenges and lab solutions in your global cell and gene therapy trials, Mar. 20, 2024 | Labcorp
share.postbeyond.com
To view or add a comment, sign in